Adaptive Biotechnologies Corp
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -172.9% | – | – | – | – | – | |
| – | +3.5% | +29.8% | +8.7% | +147.7% | +34.2% | -21.0% | -13.4% | -7.4% | |
| – | +59.1% | +17.7% | +88.7% | +74.7% | +28.3% | +13.4% | -14.8% | -4.0% | |
| – | +29.5% | +13.9% | +120.0% | +73.9% | +30.7% | – | – | – | |
| – | – | – | -116.0% | – | – | – | – | – | |
| – | +152.1% | +77.3% | +67.9% | +228.4% | -73.5% | -34.6% | -65.7% | -19.2% | |
| – | -98.0% | -65,548.0% | -75.7% | – | -98.4% | +4,362.9% | -40.0% | -51.2% | |
| – | – | – | – | – | – | – | – | – | |
| – | -97.5% | +25,523.4% | -9.6% | -90.9% | -70.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | -97.5% | +25,534.3% | -8.2% | -90.8% | +387.2% | -98.3% | -89.3% | +12,515.4% | |
| – | -158.7% | – | -38.4% | -41.8% | -413.7% | – | – | – | |
| – | – | – | -186.8% | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.